Pathogenesis of Type 2 Diabetes

[1]  T. Sanke,et al.  Simple tandem repeat DNA polymorphism in the human glycogen synthase gene is associated with NIDDM in Japanese subjects , 1994, Diabetologia.

[2]  M. Ghatei,et al.  Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans , 1994, Diabetologia.

[3]  A. Vaag,et al.  Pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycaemia. A critical comment , 1994, Diabetologia.

[4]  Y. Iwamoto,et al.  Serum proinsulin levels at fasting and after oral glucose load in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1988, Diabetologia.

[5]  G. Sesti,et al.  Insulin receptor tyrosine-kinase activity is altered in both muscle and adipose tissue from non-obese normoglycaemic insulin-resistant subjects , 2006, Diabetologia.

[6]  G. Reaven,et al.  The fourth Musketeer — from Alexandre Dumas to Claude Bernard , 2006, Diabetologia.

[7]  M. Nauck,et al.  Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes , 2006, Diabetologia.

[8]  P. Zimmet,et al.  The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance , 1978, Diabetologia.

[9]  G. Reaven,et al.  Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes , 1977, Diabetologia.

[10]  W. Butterfield,et al.  Peripheral glucose metabolism in control subjects and diabetic patients during glucose, glucose-insulin and insulin sensitivity tests , 1965, Diabetologia.

[11]  Y. Akanuma,et al.  Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment , 2005, Diabetologia.

[12]  M. White,et al.  The IRS-signalling system: A network of docking proteins that mediate insulin action , 1998, Molecular and Cellular Biochemistry.

[13]  U. Eriksson.  Lifelong consequences of metabolic adaptations in utero? , 1996, Diabetologia.

[14]  D. Phillips,et al.  Insulin resistance as a programmed response to fetal undernutrition , 1996, Diabetologia.

[15]  B. Metzger,et al.  Influences of the intrauterine metabolic environment on adult disease: what may we infer from size at birth? , 1996, Diabetologia.

[16]  K. Eriksson,et al.  Poor physical fitness, and impaired early insulin response but late hyperinsulinaemia, as predictors of NIDDM in middle-aged Swedish men , 1996, Diabetologia.

[17]  J. Bos,et al.  Expression of a dominant-negative Ras mutant does not affect stimulation of glucose uptake and glycogen synthesis by insulin , 1996, Diabetologia.

[18]  J. Maassen,et al.  Maternally inherited diabetes and deafness: a new diabetes subtype , 1996, Diabetologia.

[19]  M. Walker,et al.  Variant sequences of the Hexokinase II gene in familial NIDDM , 1996, Diabetologia.

[20]  O. Pedersen,et al.  Association of the glycogen synthase locus on 19q13 with NIDDM in Pima Indians , 1996, Diabetologia.

[21]  K. Eriksson,et al.  Human hexokinase II gene: exon-intron organization, mutation screening in NIDDM, and its relationship to muscle hexokinase activity , 1995, Diabetologia.

[22]  H. Yki-Järvinen.  Role of insulin resistance in the pathogenesis of NIDDM , 1995, Diabetologia.

[23]  H. Ikegami.  The glycogen synthase gene in NIDDM and hypertension , 1995, Diabetologia.

[24]  O. Pedersen,et al.  Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control , 1995, Diabetologia.

[25]  E. Cerasi.  Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? , 1995, Diabetologia.

[26]  H. Yki-Järvinen,et al.  Methodological aspects, dose-response characteristics and causes of interindividual variation in insulin stimulation of limb blood flow in normal subjects , 1995, Diabetologia.

[27]  M. Laakso,et al.  Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance , 1995, Diabetologia.

[28]  C. Bogardus,et al.  Molecular and linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: lack of evidence for its major role in insulin resistance in Pima Indians , 1995, Diabetologia.

[29]  M. McCarthy,et al.  Insulin receptor substrate-1 gene mutations in NIDDM; implications for the study of polygenic disease , 1995, Diabetologia.

[30]  M. Matsuda,et al.  Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man , 1994, Diabetologia.

[31]  M. McCarthy,et al.  The genetics of non-insulin-dependent diabetes mellitus: tools and aims , 1994, Diabetologia.

[32]  H. Lithell,et al.  Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men , 1994, Diabetologia.

[33]  B. Jeanrenaud.  Central nervous system and peripheral abnormalities: clues to the understanding of obesity and NIDDM , 1994, Diabetologia.

[34]  C. Hales.  The pathogenesis of NIDDM , 1994, Diabetologia.

[35]  S. Nagataki,et al.  Pancreatic beta-cell secretory defect associated with mitochondrial point mutation of the tRNALEU(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS) , 1994, Diabetologia.

[36]  M. Permutt,et al.  Variability of the pancreatic islet beta cell/liver (GLUT 2) glucose transporter gene in NIDDM patients , 1994, Diabetologia.

[37]  L. Groop,et al.  Effect of insulin on GLUT-4 mRNA and protein concentrations in skeletal muscle of patients with NIDDM and their first-degree relatives , 1994, Diabetologia.

[38]  L. Groop,et al.  Insulin resistance and insulin deficiency in the pathogenesis of Type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? , 1993, Diabetologia.

[39]  J. Morris,et al.  Chronic overproduction of islet amyloid polypeptide/amylin in transgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycaemia or hyperinsulinaemia , 1993, Diabetologia.

[40]  J. Holst,et al.  Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in Type 2 (non-insulin-dependent) diabetic patients , 1993, Diabetologia.

[41]  L. Groop,et al.  Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[42]  C. Betsholtz,et al.  Islet amyloid polypeptide: demonstration of mRNA in human pancreatic islets by in situ hybridization in islets with and without amyloid deposits , 1993, Diabetologia.

[43]  P. J. Randle.  Glucokinase and candidate genes for Type 2 (non-insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[44]  C. Hales,et al.  Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis , 1992, Diabetologia.

[45]  R. DeFronzo.  Pathogenesis of Type 2 (non-insulin dependent) diabetes mellitus: a balanced overview , 1992, Diabetologia.

[46]  L. Groop,et al.  Islet amyloid polypeptide plasma concentrations in individuals at increased risk of developing Type 2 (non-insulin-dependent) diabetes mellitus , 1992, Diabetologia.

[47]  J. Gerich.  Is muscle the major site of insulin resistance in Type 2 (non-insulin-dependent) diabetes mellitus? , 1991, Diabetologia.

[48]  P. Arner,et al.  Different aetiologies of Type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects , 1991, Diabetologia.

[49]  L. Groop,et al.  Modulation of hepatic glucose production by non-esterified fatty acids in Type 2 (non-insulin-dependent) diabetes mellitus , 1991, Diabetologia.

[50]  S. Bloom,et al.  Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man , 1990, Diabetologia.

[51]  S. Bloom,et al.  Altered islet amyloid polypeptide (amylin) gene expression in rat models of diabetes , 1989, Diabetologia.

[52]  S. O’Rahilly,et al.  Linkage analysis of the human insulin receptor gene in Type 2 (non-insulin-dependent) diabetic families and a family with maturity onset diabetes of the young , 1988, Diabetologia.

[53]  R. DeFronzo,et al.  Oxidative and non-oxidative glucose metabolism in non-obese Type 2 (non-insulin-dependent) diabetic patients , 1988, Diabetologia.

[54]  S. O’Rahilly,et al.  Type 2 (non-insulin-dependent) diabetes mellitus new genetics for old nightmares , 1988, Diabetologia.

[55]  D. Porte,et al.  Disproportionate elevation of immunoreactive proinsulin in Type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance , 1987, Diabetologia.

[56]  B. Hansen,et al.  Heterogeneity of insulin responses: phases leading to Type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey , 1986, Diabetologia.

[57]  K. Alberti,et al.  Muscle enzyme activity and insulin sensitivity in Type 1 (insulin-dependent) diabetes mellitus , 1986, Diabetologia.

[58]  C. Howard.  Longitudinal studies on the development of diabetes in individual Macaca nigra , 1986, Diabetologia.

[59]  V. Mohan,et al.  High prevalence of Type 2 (non-insulin-dependent) diabetes among the offspring of conjugal Type 2 diabetic parents in India , 1985, Diabetologia.

[60]  W. Waldhäusl,et al.  Insulin production rate, hepatic insulin retention and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinaemic Type 2 (non-insulin-dependent) diabetes mellitus , 1982, Diabetologia.

[61]  N. Kalant,et al.  Insulin responsiveness of superficial forearm tissues in Type 2 (non-insulin dependent) diabetes , 1982, Diabetologia.

[62]  C. Hales,et al.  Plasma insulin in minor abnormalities of glucose tolerance: a 5 year follow-up , 1974, Diabetologia.

[63]  D. Giugliano,et al.  Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors , 2004, European Journal of Clinical Pharmacology.

[64]  B. Ludvik,et al.  Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans , 2004, Diabetologia.

[65]  G. Reaven,et al.  Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance , 2004, Diabetologia.

[66]  E. Jéquier,et al.  Glucose storage and oxidation in different degrees of human obesity measured by continuous indirect calorimetry , 2004, Diabetologia.

[67]  G. Reaven,et al.  An attempt to define the nature of chemical diabetes using a multidimensional analysis , 2004, Diabetologia.

[68]  C. Kahn,et al.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. , 2000, The Journal of clinical investigation.

[69]  C. Kahn,et al.  Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. , 1999, The Journal of clinical investigation.

[70]  M. Quon,et al.  Action of insulin receptor substrate-3 (IRS-3) and IRS-4 to stimulate translocation of GLUT4 in rat adipose cells. , 1999, Molecular endocrinology.

[71]  E. Ravussin,et al.  Metabolic predictors of weight gain , 1999, International Journal of Obesity.

[72]  D. A. Pyke,et al.  Concordance rate for Type II diabetes mellitus in monozygotic twins: actuarial analysis , 1999, Diabetologia.

[73]  G. Shulman,et al.  Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. , 1998, The New England journal of medicine.

[74]  R. Pipek,et al.  Insulin-induced hexokinase II expression is reduced in obesity and NIDDM. , 1998, Diabetes.

[75]  A. Klip,et al.  Molecular mechanisms involved in GLUT4 translocation in muscle during insulin and contraction stimulation. , 1998, Advances in experimental medicine and biology.

[76]  A. Garber,et al.  Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. , 1997, The American journal of medicine.

[77]  R N Bergman,et al.  Reassessment of Glucose Effectiveness and Insulin Sensitivity From Minimal Model Analysis: A Theoretical Evaluation of the Single-Compartment Glucose Distribution Assumption , 1997, Diabetes.

[78]  R. DeFronzo.  PATHOGENESIS OF TYPE 2 DIABETES: METABOLIC AND MOLECULAR IMPLICATIONS FOR IDENTIFYING DIABETES GENES , 1997 .

[79]  R. DeFronzo,et al.  Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus. , 1996, The Journal of clinical endocrinology and metabolism.

[80]  P. Froguel,et al.  Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. , 1996, The Journal of clinical investigation.

[81]  P. Zimmet,et al.  Insulin Levels and the Natural History of Glucose Intolerance in Nauruans , 1996, Diabetes.

[82]  R N Bergman,et al.  Role of Glucose Effectiveness in the Determination of Glucose Tolerance , 1996, Diabetes Care.

[83]  M. McCarthy,et al.  Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by a genome scan in Finnish families , 1996, Nature Genetics.

[84]  D. McClain,et al.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. , 1996, The Journal of clinical investigation.

[85]  D. McClain,et al.  Hexosamines and Insulin Resistance , 1996, Diabetes.

[86]  O. Ljungqvist,et al.  Glucose Ingestion Causes GLUT4 Translocation in Human Skeletal Muscle , 1996, Diabetes.

[87]  Yun-ping Zhou,et al.  Inhibitory effects of fatty acids on glucose-regulated B-cell function: association with increased islet triglyceride stores and altered effect of fatty acid oxidation on glucose metabolism. , 1996, Metabolism: clinical and experimental.

[88]  A. Peiris,et al.  Interstitial insulin during euglycemic-hyperinsulinemic clamp in obese and lean individuals. , 1996, Metabolism: clinical and experimental.

[89]  B. Fielding,et al.  Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. , 1996, Metabolism: clinical and experimental.

[90]  Claudio Cobelli,et al.  Roles of Glucose Transport and Glucose Phosphorylation in Muscle Insulin Resistance of NIDDM , 1996, Diabetes.

[91]  M. Stumvoll,et al.  Glutamine and Alanine Metabolism in NIDDM , 1996, Diabetes.

[92]  Roy Taylor,et al.  Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM , 1996, Diabetes.

[93]  C. Cobelli,et al.  Intracellular lactate- and pyruvate-interconversion rates are increased in muscle tissue of non-insulin-dependent diabetic individuals. , 1996, The Journal of clinical investigation.

[94]  Simon C Watkins,et al.  The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. , 1996, The Journal of clinical investigation.

[95]  K. Petersen,et al.  Mechanism of free fatty acid-induced insulin resistance in humans. , 1996, The Journal of clinical investigation.

[96]  R. S. Spielman,et al.  A genome–wide search for human non–insulin–dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2 , 1996, Nature Genetics.

[97]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[98]  H. Iida,et al.  Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. , 1996, The Journal of clinical investigation.

[99]  J. Sturis,et al.  Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. , 1996, The New England journal of medicine.

[100]  R. DeFronzo,et al.  Increased Glutamine:Fructose-6-Phosphate Amidotransferase Activity in Skeletal Muscle of Patients With NIDDM , 1996, Diabetes.

[101]  S. Elbein,et al.  Linkage Studies of NIDDM with 23 Chromosome 11 Markers in a Sample of Whites of Northern European Descent , 1996, Diabetes.

[102]  M. Prentki,et al.  Are the β-Cell Signaling Molecules Malonyl-CoA and Cystolic Long-Chain Acyl-CoA Implicated in Multiple Tissue Defects of Obesity and NIDDM? , 1996, Diabetes.

[103]  D. McClain,et al.  Regulation of Glycogen Synthase and Protein Phosphatase-1 by Hexosamines , 1996, Diabetes.

[104]  R. Henry,et al.  The expression of TNF alpha by human muscle. Relationship to insulin resistance. , 1996, The Journal of clinical investigation.

[105]  F M Matschinsky,et al.  A Lesson in Metabolic Regulation Inspired by the Glucokinase Glucose Sensor Paradigm , 1996, Diabetes.

[106]  K. Gempel,et al.  Mitochondria and Diabetes: Genetic, Biochemical, and Clinical Implications of the Cellular Energy Circuit , 1996, Diabetes.

[107]  N. Schork,et al.  Genetic Analysis of NIDDM: The Study of Quantitative Traits , 1996, Diabetes.

[108]  J. Halter,et al.  Maturity Onset Diabetes of the Young (MODY) , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[109]  C. Cobelli,et al.  A model to measure insulin effects on glucose transport and phosphorylation in muscle: a three-tracer study. , 1996, The American journal of physiology.

[110]  D. D’Alessio,et al.  Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. , 1996, The Journal of clinical investigation.

[111]  C. Cobelli,et al.  Direct assessment of liver glycogen storage by 13C nuclear magnetic resonance spectroscopy and regulation of glucose homeostasis after a mixed meal in normal subjects. , 1996, The Journal of clinical investigation.

[112]  M. Permutt,et al.  Localization of MODY3 to a 5-cM Region of Human Chromosome 12 , 1995, Diabetes.

[113]  E. Horton,et al.  Mechanisms of Increased Skeletal Muscle Glucose Transport Activity After an Oral Glucose Load in Rats , 1995, Diabetes.

[114]  S. Haffner,et al.  Decreased Insulin Secretion and Increased Insulin Resistance Are Independently Related to the 7-Year Risk of NIDDM in Mexican-Americans , 1995, Diabetes.

[115]  T. Hansen,et al.  Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients. , 1995, The Journal of clinical investigation.

[116]  S. Mudaliar,et al.  Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. , 1995, The Journal of clinical investigation.

[117]  H. Klein,et al.  Elevation of Serum Insulin Concentration During Euglycemic Hyperinsulinemic Clamp Studies Leads to Similar Activation of Insulin Receptor Kinase in Skeletal Muscle of Subjects With and Without NIDDM , 1995, Diabetes.

[118]  E. Lander,et al.  Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results , 1995, Nature Genetics.

[119]  P. Froguel,et al.  Linkage Analyses of the MODY3 Locus on Chromosome 12q With Late-Onset NIDDM , 1995, Diabetes.

[120]  L. Groop,et al.  Isolation and Characterization of the Human Muscle Glycogen Synthase Gene , 1995, Diabetes.

[121]  R. DeFronzo,et al.  Reciprocal Variations in Insulin-Stimulated Glucose Uptake and Pancreatic Insulin Secretion in Women With Normal Glucose Tolerance , 1995, The Journal of the Society for Gynecologic Investigation: JSGI.

[122]  G Dailey,et al.  Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. , 1995, The New England journal of medicine.

[123]  R. DeFronzo,et al.  Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. , 1995, The New England journal of medicine.

[124]  A. Jula,et al.  Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. , 1995, The Journal of clinical investigation.

[125]  J. Olefsky,et al.  Kinetics of Insulin Action In Vivo: Identification of Rate-Limiting Steps , 1995, Diabetes.

[126]  R. Unger.  Lipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications , 1995, Diabetes.

[127]  P. Zimmet.  The Pathogenesis and Prevention of Diabetes in Adults: Genes, autoimmunity, and demography , 1995, Diabetes Care.

[128]  Wei Chen,et al.  In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. , 1995, The Journal of clinical investigation.

[129]  G. Dailey,et al.  Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM. Evidence from studies in normal glucose-tolerant individuals with a first-degree NIDDM relative. , 1995, JAMA.

[130]  K. Polonsky.  The β-Cell in Diabetes: From Molecular Genetics to Clinical Research , 1995, Diabetes.

[131]  P. Wahl,et al.  Earlier Appearance of Impaired Insulin Secretion Than of Visceral Adiposity in the Pathogenesis of NIDDM: 5-Year Follow-up of Initially Nondiabetic Japanese-American Men , 1995, Diabetes Care.

[132]  G. Dohm,et al.  Okadaic Acid, Vanadate, and Phenylarsine Oxide Stimulate 2-Deoxyglucose Transport in Insulin-Resistant Human Skeletal Muscle , 1995, Diabetes.

[133]  K. Cusi,et al.  Safety and Efficacy of Normalizing Fasting Glucose With Bedtime NPH Insulin Alone in NIDDM , 1995, Diabetes Care.

[134]  J. Halter,et al.  Altered Insulin Secretory Responses to Glucose in Subjects with a Mutation in the MODY1 Gene on Chromosome 20 , 1995, Diabetes.

[135]  K. Gerbitz,et al.  Mitochondrial diabetes mellitus: a review. , 1995, Biochimica et biophysica acta.

[136]  J. Sturis,et al.  Defects in Insulin Secretion and Action in Women With a History of Gestational Diabetes , 1995, Diabetes.

[137]  F. Ashcroft,et al.  No Evidence for Mutations in a Putative β-Cell ATP-Sensitive K+ Channel Subunit in MODY, NIDDM, or GDM , 1995, Diabetes.

[138]  T. Buchanan,et al.  Predicting Future Diabetes in Latino Women With Gestational Diabetes: Utility of Early Postpartum Glucose Tolerance Testing , 1995, Diabetes.

[139]  P. Damm,et al.  A Longitudinal Study of Plasma Insulin and Glucagon in Women With Previous Gestational Diabetes , 1995, Diabetes Care.

[140]  B. Spiegelman,et al.  Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.

[141]  C. Bogardus,et al.  Evidence for Linkage Between a Region on Chromosome 1p and the Acute Insulin Response in Pima Indians , 1995, Diabetes.

[142]  Francis S. Collins,et al.  Positional cloning moves from perditional to traditional , 1995, Nature Genetics.

[143]  A J Scheen,et al.  24-hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations. , 1995, The Journal of clinical investigation.

[144]  I. Stratton,et al.  Analysis of the Hexokinase II Gene in Subjects With Insulin Resistance and NIDDM and Detection of a Gln142→His Substitution , 1995, Diabetes.

[145]  J. Blangero,et al.  Evidence for a Major Gene Affecting Postchallenge Insulin Levels in Mexican-Americans , 1995, Diabetes.

[146]  T. Hansen,et al.  Identification of Four Amino Acid Substitutions in Hexokinase II and Studies of Relationships to NIDDM, Glucose Effectiveness, and Insulin Sensitivity , 1995, Diabetes.

[147]  M. Laakso,et al.  Amino Acid Substitutions in Hexokinase II Among Patients With NIDDM , 1995, Diabetes.

[148]  R. Printz,et al.  Human Hexokinase II mRNA and Gene Structure , 1995, Diabetes.

[149]  R. Shulman,et al.  Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[150]  H. Lebovitz,et al.  Does Intra-Abdominal Adipose Tissue in Black Men Determine Whether NIDDM Is Insulin-Resistant or Insulin-Sensitive? , 1995, Diabetes.

[151]  A. Vaag,et al.  Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. , 1995, The Journal of clinical investigation.

[152]  T. Hansen,et al.  Cloning of a Human Insulin-Stimulated Protein Kinase (ISPK-1) Gene and Analysis of Coding Regions and mRNA Levels of the ISPK-1 and the Protein Phosphatase-1 Genes in Muscle From NIDDM Patients , 1995, Diabetes.

[153]  J. Levy,et al.  Type II Diabetes: Clinical Aspects of Molecular Biological Studies , 1995, Diabetes.

[154]  B. Göke,et al.  Reduction of the Incretin Effect in Rats by the Glucagon-Like Peptide 1 Receptor Antagonist Exendin (9–39) Amide , 1995, Diabetes.

[155]  C. Newgard,et al.  Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.

[156]  D. Smith,et al.  Glucagon-like peptide-1 is a physiological incretin in rat. , 1995, The Journal of clinical investigation.

[157]  W. Sheu,et al.  Relationship Between Hepatic Glucose Production and Fasting Plasma Glucose Concentration in Patients With NIDDM , 1994, Diabetes.

[158]  S. Elbein,et al.  The Genetics of NIDDM: An update , 1994, Diabetes Care.

[159]  L. Groop,et al.  Hyperproinsulinemia of Type II Diabetes Is Not Present Before the Development of Hyperglycemia , 1994, Diabetes Care.

[160]  L. Berglund,et al.  The Risk to Develop NIDDM Is Related to the Fatty Acid Composition of the Serum Cholesterol Esters , 1994, Diabetes.

[161]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[162]  A Mari,et al.  Glucose absorption and production following oral glucose: comparison of compartmental and arteriovenous-difference methods. , 1994, Metabolism: clinical and experimental.

[163]  C. Palombo,et al.  Insulin resistance and vasodilation in essential hypertension. Studies with adenosine. , 1994, The Journal of clinical investigation.

[164]  D. Wallace,et al.  Mitochondrial DNA sequence variation in human evolution and disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[165]  L. Olson,et al.  Differentiating Glucose Toxicity From Glucose Desensitization: A New Message From the Insulin Gene , 1994, Diabetes.

[166]  T. Hansen,et al.  Genetic Variants in Promoters and Coding Regions of the Muscle Glycogen Synthase and the Insulin-Responsive GLUT4 Genes in NIDDM , 1994, Diabetes.

[167]  C. R. Kahn,et al.  Insulin Action, Diabetogenes, and the Cause of Type II Diabetes , 1994, Diabetes.

[168]  B. Otterud,et al.  Description of a Second Microsatellite Marker and Linkage Analysis of the Muscle Glycogen Synthase Locus in Familial NIDDM , 1994, Diabetes.

[169]  S. Chen,et al.  More Direct Evidence for a Malonyl-CoA–Carnitine Palmitoyltransferase I Interaction as a Key Event in Pancreatic β-Cell Signaling , 1994, Diabetes.

[170]  P. Bougnères,et al.  Early Changes in Postprandial Insulin Secretion, Not in Insulin Sensitivity, Characterize Juvenile Obesity , 1994, Diabetes.

[171]  E. Mosekilde,et al.  Compensation in Pancreatic β-Cell Function in Subjects With Glucokinase Mutations , 1994, Diabetes.

[172]  R. Hanson,et al.  Birth weight and non-insulin dependent diabetes: thrifty genotype, thrifty phenotype, or surviving small baby genotype? , 1994, BMJ.

[173]  C. Bogardus,et al.  Linkage Analysis of Acute Insulin Secretion With GLUT2 and Glucokinase in Pima Indians and the Identification of a Missense Mutation in GLUT2 , 1994, Diabetes.

[174]  C. Rhodes,et al.  What β-cell Defect Could Lead to Hyperproinsulinemia in NIDDM?: Some Clues From Recent Advances Made in Understanding the Proinsulin-Processing Mechanism , 1994, Diabetes.

[175]  J. Beckmann,et al.  Search for a Third Susceptibility Gene for Maturity-Onset Diabetes of the Young: Studies With Eleven Candidate Genes , 1994, Diabetes.

[176]  A. Goldberg,et al.  Impaired insulin sensitivity and maximal responsiveness in older hypertensive men. , 1994, Hypertension.

[177]  G M Steil,et al.  Dynamics of Glucose Production and Uptake Are More Closely Related to Insulin in Hindlimb Lymph Than in Thoracic Duct Lymph , 1994, Diabetes.

[178]  C. Cobelli,et al.  Assessment of Insulin Action in NIDDM in the Presence of Dynamic Changes in Insulin and Glucose Concentration , 1994, Diabetes.

[179]  J. Clore,et al.  Suppression of Gluconeogenesis After a 3-Day Fast Does Not Deplete Liver Glycogen in Patients With NIDDM , 1994, Diabetes.

[180]  Yun-ping Zhou,et al.  Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose-induced insulin secretion and biosynthesis through a glucose fatty acid cycle. , 1994, The Journal of clinical investigation.

[181]  D. Johnston,et al.  Insulin sensitivity in non‐diabetic relatives of patients with non‐insulin‐dependent diabetes from two ethnic groups , 1994, Clinical endocrinology.

[182]  P. Jansson,et al.  Lactate release from the subcutaneous tissue in lean and obese men. , 1994, The Journal of clinical investigation.

[183]  S. Lillioja,et al.  Interstitial insulin concentrations determine glucose uptake rates but not insulin resistance in lean and obese men. , 1994, The Journal of clinical investigation.

[184]  E. Ravussin,et al.  Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians. , 1993, The New England journal of medicine.

[185]  P. Froguel,et al.  Prevalence of mitochondrial gene mutations in families with diabetes mellitus , 1993, The Lancet.

[186]  H. Yki-Järvinen,et al.  Inhibition of Lipolysis Decreases Lipid Oxidation and Gluconeogenesis From Lactate But Not Fasting Hyperglycemia or Total Hepatic Glucose Production in NIDDM , 1993, Diabetes.

[187]  C. Kahn,et al.  Rad: a member of the Ras family overexpressed in muscle of type II diabetic humans. , 1993, Science.

[188]  D. Owens,et al.  Reduced Sampling Protocols in Estimation of Insulin Sensitivity and Glucose Effectiveness Using the Minimal Model in NIDDM , 1993, Diabetes.

[189]  T. Hansen,et al.  Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus , 1993, The Lancet.

[190]  B. Egan,et al.  Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men. , 1993, Hypertension.

[191]  U. Smith,et al.  Measurement by Microdialysis of the Insulin Concentration in Subcutaneous Interstitial Fluid: Importance of the Endothelial Barrier for Insulin , 1993, Diabetes.

[192]  C. Kahn,et al.  Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. , 1993, The Journal of clinical investigation.

[193]  J. Beckmann,et al.  Linkage Analysis and Molecular Scanning of Glucokinase Gene in NIDDM Families , 1993, Diabetes.

[194]  G. Waeber,et al.  Glucagon-Like Peptide-I and the Control of Insulin Secretion in the Normal State and in NIDDM , 1993, Diabetes.

[195]  Y. Ida Chen,et al.  Insulin Resistance and Insulin Secretion Are Determinants of Oral Glucose Tolerance in Normal Individuals , 1993, Diabetes.

[196]  J. Sturis,et al.  Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[197]  C. Cobelli,et al.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes. , 1993, The Journal of clinical investigation.

[198]  L. Mandarino,et al.  Interaction between glucose and free fatty acid metabolism in human skeletal muscle. , 1993, The Journal of clinical investigation.

[199]  R. Printz,et al.  The Effects of Hyperinsulinemia and Hyperglycemia on GLUT4 and Hexokinase II mRNA and Protein in Rat Skeletal Muscle and Adipose Tissue , 1993, Diabetes.

[200]  H. Vestergaard,et al.  Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[201]  C. L. Blackburn,et al.  Identification of Glucokinase Mutations in Subjects With Gestational Diabetes Mellitus , 1993, Diabetes.

[202]  P. Froguel,et al.  Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[203]  M. Davies,et al.  Insulin Deficiency Rather Than Hyperinsulinaemia in Newly Diagnosed Type 2 Diabetes Mellitus , 1993, Diabetic medicine : a journal of the British Diabetic Association.

[204]  S. Julius,et al.  Reflex sympathetic activation induces acute insulin resistance in the human forearm. , 1993, Hypertension.

[205]  S. Lillioja,et al.  Linkage of Chromosomal Markers on 4q With a Putative Gene Determining Maximal Insulin Action in Pima Indians , 1993, Diabetes.

[206]  R. Taylor,et al.  Abnormal Activation of Glycogen Synthesis in Fibroblasts from NIDDM Subjects: Evidence for an Abnormality Specific to Glucose Metabolism , 1993, Diabetes.

[207]  U. Smith,et al.  Smoking induces insulin resistance—a potential link with the insulin resistance syndrome , 1993, Journal of internal medicine.

[208]  M. Permutt,et al.  Glucokinase Gene Variants in the Common Form of NIDDM , 1993, Diabetes.

[209]  J. Beckmann,et al.  Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus. , 1993, The New England journal of medicine.

[210]  R. DeFronzo,et al.  Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus. , 1993, The Journal of clinical investigation.

[211]  D. Chisholm,et al.  The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. , 1993, The New England journal of medicine.

[212]  L. Groop,et al.  Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[213]  C Cobelli,et al.  Glucose Transport in Human Skeletal Muscle: The In Vivo Response to Insulin , 1993, Diabetes.

[214]  J S Yudkin,et al.  Impaired glucose tolerance. , 1990, BMJ.

[215]  B. Landau.  Estimating gluconeogenic rates in NIDDM. , 1993, Advances in experimental medicine and biology.

[216]  R. DeFronzo,et al.  The Metabolic Profile of NIDDM Is Fully Established in Glucose-Tolerant Offspring of Two Mexican-American NIDDM Parents , 1992, Diabetes.

[217]  Y. Nishizuka.  Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[218]  R. N. Bergman,et al.  Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study , 1992, The Lancet.

[219]  H. Lebovitz,et al.  Insulin Action in Black Americans With NIDDM , 1992, Diabetes Care.

[220]  R. Shulman,et al.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.

[221]  C. Hales,et al.  Measurement of Insulin Secretion in Type 2 Diabetes: Problems and Pitfalls , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[222]  B. Rosner,et al.  Familial Clustering of Insulin Sensitivity , 1992, Diabetes.

[223]  J. Foley,et al.  Rationale and Application of Fatty Acid Oxidation Inhibitors in Treatment of Diabetes Mellitus , 1992, Diabetes Care.

[224]  A. Klip,et al.  Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. , 1992, The Biochemical journal.

[225]  J. Holst,et al.  Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. , 1992, The New England journal of medicine.

[226]  G. Reaven,et al.  Insulin resistance and cigarette smoking , 1992, The Lancet.

[227]  L. Groop,et al.  Impaired Activation of Glycogen Synthase in People at Increased Risk for Developing NIDDM , 1992, Diabetes.

[228]  B. Kahn.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. , 1992, The Journal of clinical investigation.

[229]  G. Condorelli,et al.  NIDDM Associated With Mutation in Tyrosine Kinase Domain of Insulin Receptor Gene , 1992, Diabetes.

[230]  A. Baron,et al.  Gene Expression of GLUT4 in Skeletal Muscle From Insulin-Resistant Patients With Obesity, IGT, GDM, and NIDDM , 1992, Diabetes.

[231]  R. Shulman,et al.  31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[232]  J. Beckmann,et al.  Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus , 1992, Nature.

[233]  A. Vaag,et al.  Insulin Resistance in Skeletal Muscles in Patients With NIDDM , 1992, Diabetes Care.

[234]  A. Vaag,et al.  Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[235]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[236]  D. Kelley,et al.  Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.

[237]  R. DeFronzo,et al.  The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. , 1992, Diabetes.

[238]  A. Consoli,et al.  Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[239]  R. Leslie,et al.  Studies of diabetic twins. , 1991, Diabetes/metabolism reviews.

[240]  S. O’Rahilly,et al.  Molecular Scanning of Insulin-Responsive Glucose Transporter (GLUT4) Gene in NIDDM Subjects , 1991, Diabetes.

[241]  J. O'sullivan.  Diabetes Mellitus After GDM , 1991, Diabetes.

[242]  H. McCarthy,et al.  Neuropeptides and intestinal tract in the control of glucose Homeostasis Hypothalamic regulatory peptides and the regulation of food intake and energy balance: signals or noise? , 1991, Proceedings of the Nutrition Society.

[243]  S. Lillioja,et al.  Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. , 1991, The Journal of clinical endocrinology and metabolism.

[244]  J. Olefsky,et al.  Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. , 1991, The Journal of clinical investigation.

[245]  H. Lithell,et al.  Risk factors for developing non-insulin dependent diabetes: a 10 year follow up of men in Uppsala. , 1991, BMJ.

[246]  A. Fontbonne,et al.  Risk Factors for NIDDM in White Population: Paris Prospective Study , 1991, Diabetes.

[247]  H. Maegawa,et al.  Impaired Autophosphorylation of Insulin Receptors From Abdominal Skeletal Muscles in Nonobese Subjects With NIDDM , 1991, Diabetes.

[248]  E A Anderson,et al.  Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. , 1991, The Journal of clinical investigation.

[249]  S. O’Rahilly,et al.  Detection of Mutations in Insulin-Receptor Gene in NIDDM Patients by Analysis of Single-Stranded Conformation Polymorphisms , 1991, Diabetes.

[250]  M. Laakso,et al.  Reduced capacity and affinity of skeletal muscle for insulin-mediated glucose uptake in noninsulin-dependent diabetic subjects. Effects of insulin therapy. , 1991, The Journal of clinical investigation.

[251]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[252]  N J Cox,et al.  Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[253]  R. DeFronzo,et al.  Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression. , 1991, The Journal of clinical investigation.

[254]  L. Groop,et al.  The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. , 1991, The Journal of clinical endocrinology and metabolism.

[255]  A. Krolewski,et al.  Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. , 1990, Annals of internal medicine.

[256]  R N Bergman,et al.  Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. , 1990, The Journal of clinical endocrinology and metabolism.

[257]  A. Consoli,et al.  Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. , 1990, The Journal of clinical investigation.

[258]  L. Mandarino,et al.  Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. , 1990, The Journal of clinical investigation.

[259]  T. Jenssen,et al.  Contribution of Abnormal Muscle and Liver Glucose Metabolism to Postprandial Hyperglycemia in NIDDM , 1990, Diabetes.

[260]  R. Napoli,et al.  Glucose and gluconeogenic substrate exchange by the forearm skeletal muscle in hyperglycemic and insulin-treated type II diabetic patients. , 1990, The Journal of clinical endocrinology and metabolism.

[261]  S. Rich.  Mapping Genes in Diabetes: Genetic Epidemiological Perspective , 1990, Diabetes.

[262]  E. Jéquier,et al.  Impaired glucose tolerance and diabetes in obesity: a 6-year follow-up study of glucose metabolism. , 1990, Metabolism: clinical and experimental.

[263]  P. Björntorp,et al.  Glucose tolerance and hyperinsulinaemia in obese women: role of adipose tissue distribution, muscle fibre characteristics and androgens , 1990, Journal of internal medicine.

[264]  J. Leahy.  Natural History of β-Cell Dysfunction in NIDDM , 1990, Diabetes Care.

[265]  J. Flier,et al.  Evidence Against Altered Expression of GLUT1 or GLUT4 in Skeletal Muscle of Patients With Obesity or NIDDM , 1990, Diabetes.

[266]  C. Bengtsson,et al.  Fasting Serum Insulin Concentration and Early Insulin Response as Risk Determinants for Developing Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[267]  Lawrence A Leiter,et al.  Cellular Mechanism of Action of Metformin , 1990, Diabetes Care.

[268]  A comparison of brain glucose metabolism in diabetes as measured by positron emission tomography or by arteriovenous techniques. , 1990, Annals of medicine.

[269]  M. Laakso,et al.  Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. , 1990, The Journal of clinical investigation.

[270]  R. Rizza,et al.  Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans , 1990, Diabetes.

[271]  L. Groop,et al.  Obesity and insulin resistance in humans: a dose-response study. , 1990, Metabolism: clinical and experimental.

[272]  R. DeFronzo,et al.  Effect of metformin treatment on insulin action in diabetic rats: in vivo and in vitro correlations. , 1990, Metabolism: clinical and experimental.

[273]  D. Accili,et al.  Mutations in Insulin-Receptor Gene in Insulin-Resistant Patients , 1990, Diabetes Care.

[274]  G I Bell,et al.  Molecular Biology of Mammalian Glucose Transporters , 1990, Diabetes Care.

[275]  S. Haffner,et al.  Incidence of Type II Diabetes in Mexican Americans Predicted by Fasting Insulin and Glucose Levels, Obesity, and Body-Fat Distribution , 1990, Diabetes.

[276]  K. Sahlin,et al.  Localization of Rate-Limiting Defect for Glucose Disposal in Skeletal Muscle of Insulin-Resistant Type I Diabetic Patients , 1990, Diabetes.

[277]  S. Seino,et al.  Human Insulin-Receptor Gene , 1990, Diabetes.

[278]  L. Cantley,et al.  Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[279]  H. Datta,et al.  Amylin and amylin-amide lack an acute effect on blood glucose and insulin. , 1990, The Journal of endocrinology.

[280]  P. Bennett,et al.  Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. , 1990, Diabetes/metabolism reviews.

[281]  L. Mandarino,et al.  Contribution of Impaired Muscle Glucose Clearance to Reduced Postabsorptive Systemic Glucose Clearance in NIDDM , 1990, Diabetes.

[282]  C. Bogardus,et al.  Insulin resistance is associated with reduced fasting and insulin-stimulated glycogen synthase phosphatase activity in human skeletal muscle. , 1990, The Journal of clinical investigation.

[283]  J. Olefsky,et al.  Induction of Insulin Resistance In Vivo by Amylin and Calcitonin Gene–Related Peptide , 1990, Diabetes.

[284]  R G Shulman,et al.  Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. , 1990, The New England journal of medicine.

[285]  G. Reaven,et al.  Insulin Insensitivity in Offspring of Parents with Type 2 Diabetes Mellitus , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[286]  R. Bergman.  Toward Physiological Understanding of Glucose Tolerance: Minimal-Model Approach , 1989, Diabetes.

[287]  R. Vigneri,et al.  Defects in Insulin-Receptor Internalization and Processing in Monocytes of Obese Subjects and Obese NIDDM Patients , 1989, Diabetes.

[288]  J. Flier,et al.  Normal Insulin-Receptor cDNA Sequence in Pima Indians With NIDDM , 1989, Diabetes.

[289]  R. Bergman,et al.  Insulin transport across capillaries is rate limiting for insulin action in dogs. , 1989, The Journal of clinical investigation.

[290]  C. Betsholtz,et al.  Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. , 1989, The New England journal of medicine.

[291]  L. Groop,et al.  Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. , 1989, The New England journal of medicine.

[292]  L. Groop,et al.  Characteristics of non-insulin-dependent diabetic patients with secondary failure to oral antidiabetic therapy. , 1989, The American journal of medicine.

[293]  L. Groop,et al.  Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. , 1989, The Journal of clinical investigation.

[294]  P. Bennett,et al.  SEQUENTIAL CHANGES IN SERUM INSULIN CONCENTRATION DURING DEVELOPMENT OF NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[295]  F. Capani,et al.  Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM , 1989, Diabetes.

[296]  R. Spielman,et al.  Linkage Studies on NIDDM and the Insulin and Insulin-Receptor Genes , 1989, Diabetes.

[297]  H. Makino,et al.  Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. , 1989, Biochemical and biophysical research communications.

[298]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[299]  R. Rizza,et al.  Effects of Basal Insulin Supplementation on Disposition of Mixed Meal in Obese Patients With NIDDM , 1989, Diabetes.

[300]  R. Fletterick,et al.  Human muscle glycogen synthase cDNA sequence: a negatively charged protein with an asymmetric charge distribution. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[301]  D. Owens,et al.  INSULIN DEFICIENCY IN NON-INSULIN-DEPENDENT DIABETES , 1989, The Lancet.

[302]  S. Haffner,et al.  Increased insulin concentrations in nondiabetic offspring of diabetic parents. , 1988, The New England journal of medicine.

[303]  P. Bennett,et al.  The natural history of impaired glucose tolerance in the Pima Indians. , 1988, The New England journal of medicine.

[304]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[305]  R. DeFronzo,et al.  Metabolic basis of obesity and noninsulin-dependent diabetes mellitus. , 1988, Diabetes/metabolism reviews.

[306]  M. Laakso,et al.  Effects of hypocaloric diet and insulin therapy on metabolic control and mechanisms of hyperglycemia in obese non-insulin-dependent diabetic subjects. , 1988, Metabolism: clinical and experimental.

[307]  R. Napoli,et al.  Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance. , 1988, The Journal of clinical endocrinology and metabolism.

[308]  G. Cooper,et al.  Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro , 1988, Nature.

[309]  J. Olefsky,et al.  Reversibility of defective adipocyte insulin receptor kinase activity in non-insulin-dependent diabetes mellitus. Effect of weight loss. , 1988, The Journal of clinical investigation.

[310]  J. Olefsky,et al.  Restriction-Fragment–Length Polymorphism in Insulin-Receptor Gene and Insulin Resistance in NIDDM , 1988, Diabetes.

[311]  Yii-Der I. Chen,et al.  Measurement of Plasma Glucose, Free Fatty Acid, Lactate, and Insulin for 24 h in Patients With NIDDM , 1988, Diabetes.

[312]  S. Lillioja,et al.  Obesity and insulin resistance: lessons learned from the Pima Indians. , 1988, Diabetes/metabolism reviews.

[313]  G. Reaven,et al.  Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes. , 1988, The Journal of clinical investigation.

[314]  E. Kraegen,et al.  Physiological Importance of Deficiency in Early Prandial Insulin Secretion in Non-Insulin-Dependent Diabetes , 1988, Diabetes.

[315]  H. Beck-Nielsen,et al.  Insulin Action and Insulin Secretion in Identical Twins With MODY: Evidence for Defects in Both Insulin Action and Secretion , 1988, Diabetes.

[316]  R. DeFronzo.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[317]  B V Howard,et al.  Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. , 1988, The New England journal of medicine.

[318]  S. O’Rahilly,et al.  Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.

[319]  J. Olefsky,et al.  Day-Long Integrated Serum Insulin and C-Peptide Profiles in Patients With NIDDM: Correlation With Urinary C-Peptide Excretion , 1988, Diabetes.

[320]  R. Thirlby,et al.  Severe Diabetes Induced in Subtotally Depancreatized Dogs by Sustained Hyperglycemia , 1988, Diabetes.

[321]  G Sonnenberg,et al.  Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. , 1988, The Journal of clinical investigation.

[322]  J. Leahy,et al.  Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. , 1988, The Journal of clinical investigation.

[323]  J. Olefsky,et al.  Role of glucose transporters in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. , 1988, The Journal of clinical investigation.

[324]  H. Yki-Järvinen,et al.  Clinical benefits and mechanisms of a sustained response to intermittent insulin therapy in type 2 diabetic patients with secondary drug failure. , 1988, The American journal of medicine.

[325]  K. Polonsky,et al.  Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. , 1988, The Journal of clinical investigation.

[326]  H. Mortensen,et al.  Carbohydrate and Lipid Metabolism of Skeletal Muscle in Type 2 Diabetic Patients , 1988, Diabetic medicine : a journal of the British Diabetic Association.

[327]  V. Grill,et al.  Low insulin response: a marker of prediabetes. , 1988, Advances in experimental medicine and biology.

[328]  L. Mandarino,et al.  Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. , 1988, Metabolism: clinical and experimental.

[329]  R. DeFronzo,et al.  The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. , 1988, Metabolism: clinical and experimental.

[330]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[331]  G. Paolisso,et al.  The addition of glipizide to insulin therapy in type-II diabetic patients with secondary failure to sulfonylureas is useful only in the presence of a significant residual insulin secretion. , 1987, Acta endocrinologica.

[332]  S. Lillioja,et al.  In Vivo Insulin Action Is Familial Characteristic in Nondiabetic Pima Indians , 1987, Diabetes.

[333]  R. DeFronzo,et al.  Role of Lipid Oxidation in Pathogenesis of Insulin Resistance of Obesity and Type II Diabetes , 1987, Diabetes.

[334]  R. Rizza,et al.  Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity. , 1987, Metabolism: clinical and experimental.

[335]  J. Callés-Escandon,et al.  Loss of Early Phase of Insulin Release in Humans Impairs Glucose Tolerance and Blunts Thermic Effect of Glucose , 1987, Diabetes.

[336]  G. Eisenbarth,et al.  The "natural" history of type I diabetes. , 1987, Diabetes/metabolism reviews.

[337]  V. Grill,et al.  B cell insensitivity in a rat model of non-insulin-dependent diabetes. Evidence for a rapidly reversible effect of previous hyperglycemia. , 1987, The Journal of clinical investigation.

[338]  L. Mandarino,et al.  Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism. , 1987, The Journal of clinical investigation.

[339]  H. Yki-Järvinen,et al.  Hyperglycemia Decreases Glucose Uptake in Type I Diabetes , 1987, Diabetes.

[340]  C Bogardus,et al.  Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. , 1987, The Journal of clinical investigation.

[341]  G. Reaven,et al.  Treatment of Patients with Non‐insulin‐dependent Diabetes Mellitus: Diabetic Control and Insulin Secretion and Action After Different Treatment Modalities , 1987, Diabetic medicine : a journal of the British Diabetic Association.

[342]  A. Golay,et al.  Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. , 1987, Metabolism: clinical and experimental.

[343]  E. Cerasi,et al.  Insulin deficiency and insulin resistance in Type 2 (non‐insulin‐dependent) diabetes: quantitative contributions of pancreatic and peripheral responses to glucose homeostasis , 1987, European journal of clinical investigation.

[344]  G. Reaven,et al.  Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. , 1987, The Journal of clinical endocrinology and metabolism.

[345]  E. Ferrannini,et al.  Acute elevation of free fatty acid levels leads to hepatic insulin resistance in obese subjects. , 1987, Metabolism: clinical and experimental.

[346]  R. DeFronzo,et al.  Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats. , 1987, The Journal of clinical investigation.

[347]  G. Dohm,et al.  Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. , 1987, The Journal of clinical investigation.

[348]  S. Efendić,et al.  Glucose Tolerance, Insulin Release, and Insulin Sensitivity in Normal-Weight Women With Previous Gestational Diabetes Mellitus , 1987, Diabetes.

[349]  J. Leahy,et al.  Impaired Insulin Secretion Associated With Near Normoglycemia: Study in Normal Rats With 96-h In Vivo Glucose Infusions , 1987, Diabetes.

[350]  A. Baron,et al.  Role of Hyperglucagonemia in Maintenance of Increased Rates of Hepatic Glucose Output in Type II Diabetics , 1987, Diabetes.

[351]  A. Cherrington,et al.  Importance of the route of intravenous glucose delivery to hepatic glucose balance in the conscious dog. , 1987, The Journal of clinical investigation.

[352]  R. Sicree,et al.  Plasma Insulin Response Among Nauruans: Prediction of Deterioration in Glucose Tolerance Over 6 Yr , 1987, Diabetes.

[353]  A. Golay,et al.  Documentation of hyperglucagonemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. , 1987, The Journal of clinical endocrinology and metabolism.

[354]  N. Abumrad,et al.  Insulin, glucagon, and glucose as regulators of hepatic glucose uptake and production in vivo. , 1987, Diabetes/metabolism reviews.

[355]  H. Klein,et al.  Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. , 1987, The Journal of clinical investigation.

[356]  E. A. Sims,et al.  Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. , 1986, American journal of obstetrics and gynecology.

[357]  R. Boston,et al.  Metabolic Consequences of Prolonged Hyperinsulinemia in Humans: Evidence for Induction of Insulin Insensitivity , 1986, Diabetes.

[358]  W. J. Andrews,et al.  One month's insulin treatment of type II diabetes: the early and medium-term effects following insulin withdrawal. , 1986, Metabolism: clinical and experimental.

[359]  J. Olefsky,et al.  Blood-Brain Glucose Transfer In Diabetes Mellitus: Decreased Number of Glucose Transporters at Blood-Brain Barrier , 1986, Diabetes.

[360]  J. Olefsky,et al.  Effects of Weight Loss on Mechanisms of Hyperglycemia in Obese Non-Insulin-Dependent Diabetes Mellitus , 1986, Diabetes.

[361]  L. Disilvio,et al.  Impact of glucose ingestion on hepatic and peripheral glucose metabolism in man: an analysis based on simultaneous use of the forearm and double isotope techniques. , 1986, The Journal of clinical endocrinology and metabolism.

[362]  S. O’Rahilly,et al.  BETA-CELL DYSFUNCTION, RATHER THAN INSULIN INSENSITIVITY, IS THE PRIMARY DEFECT IN FAMILIAL TYPE 2 DIABETES , 1986, The Lancet.

[363]  S. Haffner,et al.  Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[364]  J. Silverman,et al.  Studies on the mechanism of insulin resistance in the liver from humans with noninsulin-dependent diabetes. Insulin action and binding in isolated hepatocytes, insulin receptor structure, and kinase activity. , 1986, The Journal of clinical investigation.

[365]  R. Rizza,et al.  Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. , 1986, The New England journal of medicine.

[366]  S. Lillioja,et al.  Glucose storage is a major determinant of in vivo "insulin resistance" in subjects with normal glucose tolerance. , 1986, The Journal of clinical endocrinology and metabolism.

[367]  R. Rizza,et al.  Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatic tissues. , 1986, The Journal of clinical investigation.

[368]  R. Henry,et al.  In Vivo Deactivation of Proinsulin Action on Glucose Disposal and Hepatic Glucose Production in Normal Man , 1986, Diabetes.

[369]  B. Clarke,et al.  Reversal of Insulin Resistance in Type 1 Diabetes following Initiation of Insulin Treatment , 1986, Diabetic medicine : a journal of the British Diabetic Association.

[370]  J. Halter,et al.  Insulin Resistance and Impaired Insulin Secretion in Subjects with Histories of Gestational Diabetes Mellitus , 1985, Diabetes.

[371]  R. DeFronzo,et al.  Improved Insulin Sensitivity in Patients with Type I Diabetes Mellitus After CSII , 1985, Diabetes.

[372]  G. Reaven,et al.  How insulin resistant are patients with noninsulin-dependent diabetes mellitus? , 1985, The Journal of clinical endocrinology and metabolism.

[373]  R. DeFronzo,et al.  Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus. , 1985, The Journal of clinical investigation.

[374]  R. DeFronzo,et al.  The Disposal of an Oral Glucose Load in Healthy Subjects: A Quantitative Study , 1985, Diabetes.

[375]  R. Hamman,et al.  The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus , 1985, Diabetes.

[376]  J. Halter,et al.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. , 1984, The Journal of clinical investigation.

[377]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[378]  R. DeFronzo,et al.  Mechanism of Improvement in Glucose Metabolism After Chronic Glyburide Therapy , 1984, Diabetes.

[379]  H. Yki-Järvinen,et al.  Insulin sensitivity in newly diagnosed type 1 diabetics after ketoacidosis and after three months of insulin therapy. , 1984, The Journal of clinical endocrinology and metabolism.

[380]  H. Beck-Nielsen,et al.  Improved In Vivo Insulin Effect During Continuous Subcutaneous Insulin Infusion in Patients with IDDM , 1984, Diabetes.

[381]  G. Reaven,et al.  A Comparison of the Relative Effects of Obesity and Non-insulin-dependent Diabetes Mellitus on In Vivo Insulin-stimulated Glucose Utilization , 1984, Diabetes.

[382]  J. Leahy,et al.  Abnormal Glucose Regulation of Insulin Secretion in Models of Reduced B-Cell Mass , 1984, Diabetes.

[383]  S. Efendić,et al.  Aspects of the pathogenesis of type 2 diabetes. , 1984, Endocrine reviews.

[384]  W. J. Andrews,et al.  Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal , 1984, Diabetes.

[385]  H. Yki-Järvinen,et al.  Continuous subcutaneous insulin infusion therapy decreases insulin resistance in type 1 diabetes. , 1984, The Journal of clinical endocrinology and metabolism.

[386]  J. A. Scarlett,et al.  The Acute and Chronic Effects of Sulfonylurea Therapy in Type II Diabetic Subjects , 1984, Diabetes.

[387]  S. Lillioja,et al.  Relationship between obesity and maximal insulin-stimulated glucose uptake in vivo and in vitro in Pima Indians. , 1984, The Journal of clinical investigation.

[388]  L. Mandarino,et al.  Use of Glucose Uptake and Glucose Clearance for the Evaluation of Insulin Action In Vivo , 1984, Diabetes.

[389]  P. Lönnroth,et al.  Reversal of insulin resistance in type I diabetes after treatment with continuous subcutaneous insulin infusion. , 1983, British medical journal.

[390]  G. Reaven,et al.  Insulin secretion and action in noninsulin-dependent diabetes mellitus. Is insulin resistance secondary to hypoinsulinemia? , 1983, The American journal of medicine.

[391]  R. DeFronzo,et al.  Effect of fatty acids on glucose production and utilization in man. , 1983, The Journal of clinical investigation.

[392]  S. Blumenthal.  Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: evidence that this effect can be dissociated from the provision of reducing equivalents. , 1983, Metabolism: clinical and experimental.

[393]  R. DeFronzo,et al.  Splanchnic and Peripheral Disposal of Oral Glucose in Man , 1983, Diabetes.

[394]  J. A. Scarlett,et al.  Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus. , 1983, The Journal of clinical endocrinology and metabolism.

[395]  B. Portha,et al.  Glucose Insensitivity and Amino-acid Hypersensitivity of Insulin Release in Rats with Non-insulin-dependent Diabetes: A Study with the Perfused Pancreas , 1983, Diabetes.

[396]  R. DeFronzo,et al.  New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus. , 1983, The American journal of medicine.

[397]  R. DeFronzo,et al.  Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.

[398]  R. DeFronzo,et al.  Effect of long chain triglyceride infusion on glucose metabolism in man. , 1982, Metabolism: clinical and experimental.

[399]  R. DeFronzo,et al.  The Effect of Graded Doses of Insulin on Total Glucose Uptake, Glucose Oxidation, and Glucose Storage in Man , 1982, Diabetes.

[400]  W. Millington,et al.  Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[401]  L. Orci,et al.  Quantitation of Endocrine Cell Content in the Pancreas of Nondiabetic and Diabetic Humans , 1982, Diabetes.

[402]  R. DeFronzo,et al.  Influence of Plasma Glucose and Insulin Concentration on Plasma Glucose Clearance in Man , 1982, Diabetes.

[403]  G. Reaven,et al.  Effect of Variations in Basal Plasma Glucose Concentration on Glucose Utilization (M) and Metabolic Clearance (MCR) Rates During Insulin Clamp Studies in Patients with Non-insulin-dependent Diabetes Mellitus , 1982, Diabetes.

[404]  J. P. Moulin,et al.  The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia. , 1982, Metabolism: clinical and experimental.

[405]  S. Aronoff,et al.  Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. , 1982, The Journal of clinical endocrinology and metabolism.

[406]  L. Mandarino,et al.  Mechanism and Significance of Insulin Resistance in Non-insulin-dependent Diabetes Mellitus , 1981, Diabetes.

[407]  R. DeFronzo,et al.  The Effect of Insulin on the Disposal of Intravenous Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous Catheterization , 1981, Diabetes.

[408]  A. Gjedde,et al.  Blood-brain glucose transfer: repression in chronic hyperglycemia. , 1981, Science.

[409]  J D Best,et al.  Glucose Disposal is Not Proportional to Plasma Glucose Level in Man , 1981, Diabetes.

[410]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[411]  K. Alberti,et al.  Metabolic studies in unaffected co-twins of non-insulin-dependent diabetics. , 1981 .

[412]  J. Olefsky,et al.  Effects of insulin incubation on insulin binding, glucose transport, and insulin degradation by isolated rat adipocytes. Evidence for hormone-induced desensitization at the receptor and postreceptor level. , 1980, The Journal of clinical investigation.

[413]  S. Stanik,et al.  Insulin secretion improves following dietary control of plasma glucose in severely hyperglycemic obese patients. , 1980, Metabolism: clinical and experimental.

[414]  R. DeFronzo.  Glucose Intolerance and Aging: Evidence for Tissue Insensitivity to Insulin , 1979, Diabetes.

[415]  Tohru Takahashi,et al.  Differential volumetry of A, B and D cells in the pancreatic islets of diabetic and nondiabetic subjects. , 1979, The Tohoku journal of experimental medicine.

[416]  P. Savage,et al.  Diet-induced improvement of abnormalities in insulin and glucagon secretion and in insulin receptor binding in diabetes mellitus. , 1979, The Journal of clinical endocrinology and metabolism.

[417]  J. Halter,et al.  Potentiation of insulin secretory responses by plasma glucose levels in man: evidence that hyperglycemia in diabetes compensates for imparied glucose potentiation. , 1979, The Journal of clinical endocrinology and metabolism.

[418]  R. DeFronzo,et al.  Insulin sensitivity and insulin binding to monocytes in maturity-onset diabetes. , 1979, The Journal of clinical investigation.

[419]  P. Zimmet.  Bimodality of Fasting and Two-hour Glucose Tolerance Distributions in a Micronesian Population , 1978, Diabetes.

[420]  P. Felig,et al.  Influence of Maturity-onset Diabetes on Splanchnic Glucose Balance After Oral Glucose Ingestion , 1978, Diabetes.

[421]  E. Jéquier,et al.  Carbohydrate and Lipid Oxidation in Normal and Diabetic Subjects , 1977, Diabetes.

[422]  G. Reaven,et al.  Insulin Binding in Diabetes: Relationships with Plasma Insulin Levels and Insulin Sensitivity , 1977, Diabetes.

[423]  C. J. Goodner,et al.  Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys. , 1977, Science.

[424]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[425]  R. DeFronzo,et al.  The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. , 1975, The Journal of clinical investigation.

[426]  G. Reaven,et al.  Demonstration of insulin resistance in untreated adult onset diabetic subjects with fasting hyperglycemia. , 1975, The Journal of clinical investigation.

[427]  P. Savage,et al.  INSULIN RESPONSES TO ORAL CARBOHYDRATE IN TRUE PREDIABETICS AND MATCHED CONTROLS , 1975, The Lancet.

[428]  R. Gleason,et al.  Oral Glucose-stimulated Insulin Release in Nondiabetic Twin Siblings of Diabetic Twins , 1974, Diabetes.

[429]  P. Felig,et al.  Splanchnic glucose and amino acid metabolism in obesity. , 1974, The Journal of clinical investigation.

[430]  J. Moorhouse,et al.  Glucose turnover and disposal in maturity-onset diabetes. , 1973, The Journal of clinical investigation.

[431]  R. A. Jackson,et al.  Relationship Between the Basal Glucose Concentration Glucose Tolerance and Forearm Glucose Uptake in Maturity-onset Diabetes , 1973, Diabetes.

[432]  J. Holm,et al.  The Glucose Uptake of Human Adipose Tissue in Obesity , 1971, European journal of clinical investigation.

[433]  G. Reaven,et al.  Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes. , 1970, The Journal of clinical investigation.

[434]  C. R. Morgan,et al.  Insulin patterns prior to and after onset of diabetes. , 1969, Metabolism: clinical and experimental.

[435]  D. Pyke,et al.  Glucose tolerance and serum insulin in unaffected identcal twins of diabetics. , 1967, British medical journal.

[436]  E. Cerasi,et al.  Insulin response to glucose infusion in diabetic and non-diabetic monozygotic twin pairs. Genetic control of insulin response? , 1967, Acta endocrinologica.